Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.140
+0.080 (7.55%)
At close: Apr 13, 2026, 4:00 PM EDT
1.100
-0.040 (-3.51%)
After-hours: Apr 13, 2026, 5:59 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025
Period Ending
Dec '25
Drug Delivery Systems
6.20K
Total
6.20K

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025
Period Ending
Dec '25
United States
6.15K
Canada
30.00
United Kingdom
19.00
Total
6.20K
Source: S&P Global Market Intelligence.